2024-11-16 16:00:21
OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa
Corporate/ 2023-07-23
OliX Pharmaceuticals Expands Ocular Dise...

SUWON,South Korea,May 10,2019-- OliX Pharmaceuticals,Inc. (KOSDAQ: 226950),a leading developer of RNAi therapeutics,announced todayan expans...

EnGeneIC Announces First Patients with Advanced-Stage Pancreatic Cancer Dosed in Phase 1/2a Clinical Study of Targeted Cytotoxic Immunotherapy
Health/ 2023-07-22
EnGeneIC Announces First Patients with A...

NEW YORK and SYDNEY,May 10,2019--EnGeneIC Limited,a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platfo...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release